Plasma insulin response to glucose infusion in obese non-diabetic and diabetic subjects. 1980

J Velemínský

The glucose infusion test (GIT) was performed in 10 controls, 30 obese non-diabetic subjects and 10 obese insulin-nondependent diabetics. After a priming glucose injection of 500 mg/kg, glucose was infused during one hour at a rate of 20 mg/kg/min. In healthy persons there was a biphasic plasma insulin curve with the first peak 3 min. after the start of glucose injection and a second one at 60 min. In 20 obese subjects with normal OGTT, both the initial and the later plasma insulin responses to glucose infusion were higher than in controls. In 10 obese subjects with mild glucose intolerance the average initial plasma resembled that of obese subjects with a normal OGTT. In overt mild diabetes the insulin levels during the initial phase of the GIT were diminished, but a somewhat higher, though markedly delayed, rise of insulin levels could be shown during the second hour. When calculated as sums of plasma insulin increments at 3 + 5 min., one low response in 10 controls, no low response in 20 obese subjects with a normal OGTT, but 5 low responses in 10 obese subjects with a border-line OGTT and 9 low or very low responses in 10 obese diabetics were observed.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

J Velemínský
January 1986, International journal of obesity,
J Velemínský
February 1981, JPMA. The Journal of the Pakistan Medical Association,
J Velemínský
November 1988, Clinica chimica acta; international journal of clinical chemistry,
J Velemínský
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
Copied contents to your clipboard!